文献速递毛发、甲与色素性疾病

白癜风共享决策工具的国际开发与验证

Development of a shared decision-making tool in vitiligo: an international study.
PubMed 文献 · Br J Dermatol · 2021-06-16

本研究于2019年3月至2020年3月开展前瞻性横断面研究,先通过定性研究识别30例白癜风患者治疗决策相关的91个话题,经多学科工作组和e-Delphi共识开发出包含8张A5卡片的共享决策工具,认知访谈证实其满意度、可读性和实用性,并完成英文翻译和文化验证。

要点

  • 白癜风共享决策工具包含8张A5卡片,覆盖面部/身体复色、脱色、疾病应对等话题。
  • 定性研究识别91个治疗决策话题,聚类为一般治疗目标与优先级、各治疗特异性话题两组。
  • 工具经多学科共识和认知访谈验证,并完成英文翻译及美国患者文化验证。

核心结论

  • 开发了用于非节段性白癜风的共享决策工具,并完成英文翻译和美国患者文化验证以确保通用性。

研究设计与样本

  • 前瞻性横断面研究,2019年3月至2020年3月开展,定性研究纳入30例白癜风患者,采用锚定理论方法,并通过多学科工作组和e-Delphi共识开发工具。

主要发现

  • 定性研究识别出91个与治疗决策相关的话题,层次聚类分析确认这些话题分布在两个亚组:一般治疗目标与优先级,以及每种治疗的特异性话题。
  • 共享决策工具由8张A5卡片组成,分别涉及面部复色、身体复色(局限区域)、身体复色(扩展区域)、部分或完全脱色、疾病应对、疾病稳定、维持复色和疾病信息。
  • 认知访谈证实了工具的满意度、可读性和实用性。

关键数值与推荐

  • 共享决策工具包含8张A5卡片,覆盖面部复色、身体复色(局限/扩展)、部分或完全脱色、疾病应对、疾病稳定、维持复色和疾病信息。

临床怎么用

  • 该工具可用于非节段性白癜风专科会诊中的医患共同决策,促进治疗目标与优先级的讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shared decision-making tools (SDMt) are visual tools developed to promote joint medical decisions between physicians and patients. There is a paucity of such tools in dermatology. OBJECTIVES: To develop and validate a SDMt for use in specialized consultation for vitiligo. METHODS: A prospective cross-sectional study was carried out from March 2019 to March 2020. We first conducted a qualitative study of topics discussed by patients and clinicians during therapeutic decision-making in the setting of a specialized consultation for vitiligo using an anchored-theory method, which allowed conceptualization of the SDMt. The usefulness of the SDMt was evaluated by a working group of multidisciplinary health workers and patients with vitiligo. Consensus on the final tool was obtained through an e-Delphi method. RESULTS: We recruited 30 patients with vitiligo for the qualitative study, which identified 91 topics related to therapeutic decision-making. Hierarchical clustering analysis confirmed the distribution of these topics in two subgroups (general treatment goals and priorities, and topics specific to each treatment). The consensus of a multidisciplinary group was used to develop the SDMt. The tool was comprised of eight A5 cards, which addressed face repigmentation; body repigmentation (limited area); body repigmentation (extended area); partial or complete depigmentation; coping with the disease; stabilization of disease; maintaining repigmentation; and disease information. Cognitive interviews confirmed the satisfaction, readability and usefulness of the SDMt. The SDMt was then translated and culturally validated in English. CONCLUSIONS: We developed a tool for shared decision-making in nonsegmental vitiligo, which we translated and cross-culturally validated in a US patient population with vitiligo to ensure its generalizability.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Shourick J, Ahmed M, Seneschal J, et al. Development of a shared decision-making tool in vitiligo: an international study. Br J Dermatol. 2021. PMID: 33830502. doi:10.1111/bjd.20137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。